China Journal of Leprosy and Skin Diseases ›› 2025, Vol. 41 ›› Issue (3): 226-230.doi: 10.12144/zgmfskin202503226

• Reviews • Previous Articles     Next Articles

Chronic disease management of psoriasis

LIN Zhaoping1,2,3, CHEN Chaofeng1,2, GAO Jing4,5, HUANG Cong1,2, YU Bo1,2, SHEN Changbing1,2,3   

  1. 1 Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen 518036, China; 2 Institute of Dermatology, Peking University and Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, China; 3 Shantou University Medical College, Shantou 515041, China; 4 Department of Dermatology and Venereology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China; 5 Anhui Provincial Institute of Translational Medicine, Hefei 230032, China
  • Online:2025-03-15 Published:2025-03-03

Abstract: At present, many countries and regions have released psoriasis diagnosis and treatment guidelines or expert consensus, and the concept of chronic disease management of psoriasis has gradually been reflected in the guidelines or expert consensus. From the management dimension of psoriasis treatment, based on domestic and foreign guidelines or expert consensus, we summarize the key points that need to be noted by medical staff, patients and their families during the psoriasis treatment, including traditional treatment management, small molecule targeted drug treatment management, biological agent treatment management, and comorbidity treatment management, aiming to provide guidance for chronic disease management of psoriasis.

Key words: psoriasis, management of chronic disease, guideline, expert consensus, interpretation